Effect of a Weight Loss and Lifestyle Intervention on Dietary Behavior in Men with Obstructive Sleep Apnea: The INTERAPNEA Trial
Authors:
Open Access
Abstract
This study investigated the effects of an eight-week interdisciplinary weight loss and lifestyle intervention on dietary behavior in men who were overweight/had obesity and moderate-to-severe obstructive sleep apnea (OSA). It was based on data from INTERAPNEA (ClinicalTrials.gov ID: NCT03851653); a randomized clinical trial conducted from April 2019 to April 2020. Men aged 18–65 years with moderate-to-severe OSA and a body mass index ≥25 kg/m2 were randomly assigned to a usual-care group or an eight-week interdisciplinary weight loss and lifestyle intervention combined with usual-care. Dietary behavior was assessed through the Food Behavior Checklist (FBC) and the Mediterranean Diet Adherence Screener (MEDAS). Of the 89 participants who underwent randomization, 75 completed the intervention endpoint assessment, 89 participants being therefore included in the intention-to-treat analyses, and 75 in the per-protocol approach. As compared with usual-care, the intervention group had greater improvements at intervention endpoint in dietary behavior, as measured by the FBC total score (20% increase in FBC total score, mean between-group difference, 8.7; 95% confidence interval, 5.7 to 11.7), and MEDAS total score (33% increase in MEDAS total score, mean between-group difference, 2.1; 95% CI 1.3 to 2.9). At 6 months after intervention, the intervention group also had greater improvements in both the FBC total score (15% increase) and MEDAS total score (25% increase), with mean between-group differences of 7.7 (CI 95%, 4.4 to 10.9) and 1.7 (CI 95%, 0.9 to 2.6), respectively. An eight-week interdisciplinary weight loss and lifestyle intervention resulted in meaningful and sustainable improvements in dietary behavior, including adherence to the Mediterranean diet in men who were overweight/ had obesity and CPAP-treated moderate-to-severe OSA.Keywords
Funding Information
- the Spanish Ministry of Education and Vocational Training (FPU16/01093, FPU14/04172, FPU19/01609, SOMM17/6107/UGR)
- the University of Granada-LoMonaco S.L. Sleep Research Cathedra (FPU16/01093, FPU14/04172, FPU19/01609, SOMM17/6107/UGR)
- the University of Granada Plan Propio de Investigación 2016–Excellence actions: Unit of Excellence on Exercise and Health (UCEES) and the Regional Ministry of Economy, Knowledge, Enterprise, and Universities (CECEU) of Andalusia (FPU16/01093, FPU14/04172, FPU19/01609, SOMM17/6107/UGR)
This publication has 52 references indexed in Scilit:
- Effectiveness of Lifestyle Interventions on Obstructive Sleep Apnea (OSA): Systematic Review and Meta-AnalysisSLEEP, 2013
- The reciprocal interaction between obesity and obstructive sleep apnoeaSleep Medicine Reviews, 2013
- Looking back at Look AHEAD—giving lifestyle a chanceNature Reviews Cardiology, 2013
- Regulation of Food Intake, Energy Balance, and Body Fat Mass: Implications for the Pathogenesis and Treatment of ObesityThe Journal of Clinical Endocrinology & Metabolism, 2012
- A Short Screener Is Valid for Assessing Mediterranean Diet Adherence among Older Spanish Men and WomenThe Journal of Nutrition, 2011
- Assessing factorial and convergent validity and reliability of a food behaviour checklist for Spanish-speaking participants in US Department of Agriculture nutrition education programmesPublic Health Nutrition, 2011
- Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trialBMJ, 2009
- A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesThe Sleep AHEAD StudyEffect of Weight Loss on Obstructive Sleep ApneaArchives of internal medicine (1960), 2009
- Continuous Positive Airway Pressure for Obstructive Sleep ApneaNew England Journal of Medicine, 2007
- Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetesControlled Clinical Trials, 2003